SDGR (SDGR)

$14.94
-5.44%
$1.1B
Market Cap
P/E Ratio
1.58
Beta
Dividend Yield
Piotroski 4/9Altman Z 0.3 DistressBeneish M -3.21 CleanROIC−WACC -38.2%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 4/9, Altman Z 0.3. DCF fair value of $4 implies 68% downside based on model assumptions.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of this entity reveal a severe capital allocation challenge, underscored by an ROIC-WACC spread of -38.2%, indicating that value is being systematically destroyed relative to the cost of equity and debt. While revenue growth remains robust at 23.3% YoY, this expansion occurs within a deeply deteriorated margin profile where net margins have contracted to -40.4%, despite gross margins holding steady at 55.7%. This divergence suggests that operating expenses are eroding top-line gains rather than contributing to bottom-line accretion. Financial stability metrics further exacerbate these concerns; the Altman Z-Score of 0.3 signals a high probability of distress, and the negative ROIC confirms an inability to generate returns on invested capital. Although the Beneish M-Score of -3.21 points toward low earnings manipulation risk per standard models, this does not offset the structural weakness in profitability or the weak Piotroski F-Score of 4/9, which reflects a lack of financial strength and operating efficiency improvements over time.

Valuation multiples reflect these underlying operational headwinds, with current pricing significantly diverging from intrinsic value estimates derived from discounted cash flow analysis. The DCF model implies a fair value of $4 per share, resulting in an implied downside of 68.2% from recent levels, suggesting the market has already priced in substantial future deterioration or that current expectations are overly optimistic regarding long-term cash generation capabilities. This disconnect is reinforced by factor-based data showing significant underperformance; the stock exhibits a Fama-French Alpha of -9.21% annually and carries heavy negative exposure to both value (HML: -0.511) and profitability factors (RMW: -1.904). These metrics indicate that relative to its peers, the security has consistently underperformed on growth-adjusted returns while lacking the defensive characteristics of a value tilt or the earnings power required for premium valuation support.

The convergence of negative alpha, severe profitability factor drag, and distressed financial health ratios creates a high-risk profile where potential upside is heavily constrained by execution risks regarding margin expansion and solvency. While the low Beneish score offers some assurance that reported figures are not aggressively manipulated upward, the fundamental reality of negative spreads and near-insolvency metrics suggests limited capacity for sustainable recovery without significant strategic restructuring or market conditions improving drastically to support higher cost-of-capital assumptions.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive
Market Price
$14.94
Fair Value
$4
Implied Upside
-75.7%
$4IMPLIED FAIR VALUEOVERVALUEDOVERUNDER
Growth Rate (Y1–5)25%
-10%20%50%
Discount Rate (WACC)13.7%
5%12.5%20%

5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.

Reverse DCFMarket-Implied
29.3%annual FCF growth priced in at $14.94

The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 23% YoY revenue.

Sensitivity Matrix

TG ↓ / WACC →11.7%13.7%15.7%
2%$4$4$3
3%$4$4$3
4%$4$4$3

Center = base case. Green = >10% upside, Red = >10% downside vs $14.94.

Pre-computed DCF: WACC=13.7%, terminal growth 3%. Fair value $4 (-68.2%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

4/9
Piotroski F-Score
Average — mixed operational signals
0.3
Altman Z-Score
Distress Zone — below 1.8 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-3.21
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

55.7%
Gross Margin
-40.4%
Net Margin
-24.6%
ROIC
13.7%
WACC
ROIC − WACC Spread: -38.2%— Negative spread.
+23.3%
Revenue Growth (YoY)
+44.8%
Earnings Growth (YoY)
12.5M
Free Cash Flow

Balance Sheet Health

0.99x
Debt / Equity
2.75x
Current Ratio
1.78%
FCF Yield
-160.9M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $-0.81
Act: $-0.64
+21.0%
Q3
✗ Miss
Est: $-0.64
Act: $-0.65
-1.6%
Q2
✓ Beat
Est: $-0.74
Act: $-0.57
+23.0%
Q1
✗ Miss
Est: $-0.09
Act: $-0.18
-100.2%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Risk Profile

62.7%
Annual Volatility
-0.71
Sharpe (1Y)
-0.21
Sharpe (3Y)
-80.0%
Max Drawdown (3Y)
-85.9%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

1.04
Market β
Mkt-RF
+1.452
Size (SMB)
Small-cap tilt
-0.511
Value (HML)
Growth tilt
-1.904
Profit (RMW)
Weak
+0.194
Invest (CMA)
Conservative
Alpha (annual): -9.21%
R²: 34.9%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

-9.7
Forward P/E
PEG Ratio
3.61
Price/Book
1M
Avg Volume
$27.63
52W High
$10.95
52W Low
24%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$43M
Tracked Passive Exposure
6
ETFs Holding SDGR
0.05%
Avg Weight in ETFs
$89B
Total ETF AUM

When investors buy or sell ETFs like ARKG or SLYG, the fund manager is mechanically forced to buy or sell SDGR shares regardless of SDGR's individual fundamentals. We estimate $43M of passive capital is structurally linked to SDGR through 6 tracked ETFs. Passive flows have a limited but growing influence on SDGR's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in SDGR to visualize passive redemption contagion across ETFs and collateral stocks.

SDGR Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
SDGREpicenterVBKETFVHTETFSPSMETFLLYLow RiskJNJLow RiskTWSTLow RiskCRSPLow RiskTEMHigh Risk
SDGR Price Drop (%)0

If SDGR (SDGR) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Eli Lilly & Co. (LLY) as the most exposed collateral stock, sharing 1 ETFs with SDGR. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

SDGR Ownership Dynamics

Passive funds hold 1 in every 17 SDGR shares, reducing daily market volatility.

Ticker
SDGR
Total Shares
66M
ETF Lock-Up
5.7%
Display Mode
Total Float Impact
5.7%Locked Float

SDGR (SDGR) exerts measurable gravity on the passive index market, currently representing 2.2% of the ARK Genomic Revolution ETF (ARKG) and 0.1% of the SLYG (SLYG). Across 6 tracked ETFs, approximately 4M shares (5.7% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

SDGR Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
SDGR
PRICE
$14.94
FLOOR (POC)
$12.20
STRENGTH
High
$1110%$12POC 15%$1311%$14$15$14.94$16$16$17$187%$1910%$2010%$219%$217%$22$23$24$25$26$26$27
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for SDGR over the past year sits near $12.20 (15% of 252-day volume). The current price of $14.94 trades 22.5% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (15% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1117,100$13.13$224,523
2026-05-0625,818$12.87$332,277.66
2026-04-291,568$12.24$19,192.32
2026-04-201,043$12.34$12,870.62
2026-04-09834$11.50$9,591
2026-03-318,405$11.07$93,043.35
2026-03-1844,643$12.29$548,662.47
2026-03-167,517$12.51$94,037.67
2026-03-13397$12.16$4,827.52
2026-02-056,613$13.36$88,349.68
2026-01-26450$16.42$7,389
2026-01-0731$18.79$582.49
2026-01-058,075$17.98$145,188.5
2026-01-0238,851$17.88$694,655.88
2025-12-3121$17.80$373.8
2025-12-3069$17.84$1,230.96
2025-12-233$19.39$58.17
2025-12-161,296$18.21$23,600.16
2025-11-26185$17.45$3,228.25
2025-11-2110$16.33$163.3
2025-11-1238$18.30$695.4
2025-10-27328$22.52$7,386.56
2025-10-24470$21.96$10,321.2
2025-10-024,915$21.21$104,247.15

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
RXRX0.5980.597Moderate
ABSI0.5380.496Moderate
CRSP0.5110.525Moderate
BEAM0.4720.497Moderate
BFLY0.4320.551Moderate
TWST0.4180.494Moderate
PRME0.4120.498Moderate
J0.4090.498Moderate
NTLA0.4040.437Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare SDGR to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.